Pacific Bio Co., Ltd. (KOSDAQ:A060900) announced a private placement of 21th series unregistered unsecured private convertible bonds for gross proceeds of KRW 2,000,000,000 on January 12, 2017. The transaction will included participation from individual investors, Seo, Wanseok for KRW 1,000,000,000, Han, Hyejung for KRW 300,000,000, Choi, Kyumyung for KRW 300,000,000, Lee, Mingu for KRW 200,000,000 and Hong, Sunghoon for KRW 200,000,000. The bonds are zero-coupon and have yield to maturity of 3% and would mature on January 11, 2020. The bonds will be fully convertible into 1,388,886 shares of the company at a fixed conversion price of KRW 1,440 per share between the period of January 12, 2018 to January 10, 2020. The subscription date and the expected payment date of the transaction is January 12, 2017.